Delivery Order SPE2DB20D2104-SPE2DB24FR70N

Award Date 12/18/23
Potential Completion Date 12/19/23
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,263.60 firm fixed-price delivery order is for the supply of ALPHAGAN P 0.15% eye drops in 5ml containers. The contract has an ultimate completion date of March 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $1,082.30 Firm Fixed Price Delivery Order contract is for "ALPHAGAN P 0.15% EYE DROPS 5ML" and has an ultimate completion date of December 27, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,889.84 Firm Fixed Price Delivery Order is for the supply of ALPHAGAN P 0.15% eye drops, a specialty medication. The contract has an ultimate completion date of September 29, 2023 and was awarded on September 28, 2023. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,174.43 firm fixed-price delivery order is for the procurement of ALPHAGAN P 0.15% eye drops, a topical ophthalmic medication. The contract has a period of performance ending on March 21, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.55 firm fixed-price delivery order is for the supply of ALPHAGAN P 0.1% eye drops, a medication used to treat glaucoma. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of a pharmaceutical product, ALPHAGAN 0.15% 10ML 1S. The award has a ceiling value of $1,479.09 and a completion date of June 3, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,207.92, is for the delivery of ALPHAGAN P 0.1% DROPS 10ML, a pharmaceutical product. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any major subcontractors. The DLA, a defense...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,717.97 Firm Fixed Price contract is for the delivery of Alphagan P 0.15% eye drops, a medication used to treat glaucoma. The contract has a completion date of June 29, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,154.52, is for the supply of ALPHAGAN P 0.15% eye drops in 5 ml containers. The contract has an ultimate completion date of July 5, 2023 and does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,789.13, is for the delivery of Alphagan P 0.1% eye drops, with a completion date of July 5, 2024. This contract is a firm fixed-price delivery order, and it is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a larger Indefinite...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FR70N
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,852.29 Firm Fixed Price delivery order is for the supply of ALPHAGAN P 0.1% DROPS 15ML, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2023.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of the company's broader contractual relationship with the DLA to deliver critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 5/13/25, 10:20 AM